Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Iron deficiency anaemia represents a major public health problem, particularly in infants, young children, pregnant women, and females with heavy menses. Oral iron supplementation is a cheap, safe, and effective means of increasing haemoglobin levels and restoring iron stores to prevent and correct iron deficiency. Many preparations are available, varying widely in dosage, formulation (quick or prolonged release), and chemical state (ferrous or ferric form). The debate over the advantages of ferrous versus ferric formulations is ongoing. In this literature review, the tolerability and efficacy of ferrous versus ferric iron formulations are evaluated. We focused on studies comparing ferrous sulphate preparations with ferric iron polymaltose complex preparations, the two predominant forms of iron used. Current data show that slow-release ferrous sulphate preparations remain the established and standard treatment of iron deficiency, irrespective of the indication, given their good bioavailability, efficacy, and acceptable tolerability demonstrated in several large clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, an important unexplained clinical limitation of oral iron therapy is that it often causes significant gastrointestinal (GI) side effects such as constipation, abdominal pain, nausea, and bloating [5-7].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oral iron is the most common treatment for ID and IDA due to its low cost, high bioavailability and effectiveness [5,6].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,857
Bothwell, T. H., Charlton, R. W., Cook, J. D., & Finch, C. A. (1979) · Blackwell Scientific Publications eBooks · Cited by 730
Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia
Stoltzfus, R. J., & Dreyfuss, M. L. (1998) · Cited by 625
Hercberg, S., Preziosi, P., Briançon, S., Galan, P., Triol, I., Malvy, D., Roussel, A.-M., & Favier, A. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00015-4 · Cited by 358
Demaeyer, E. M. (1989) · Cited by 344
Tolerability of different oral iron supplements: a systematic review
Cancelo-Hidalgo, M. J., Castelo-Branco, C., Palacios, S., Haya-Palazuelos, J., Ciria-Recasens, M., Manasanch, J., & Pérez-Edo, L. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761599 · Cited by 320
Hepcidin: from discovery to differential diagnosis
Kemna, E. H. J. M., Tjalsma, H., Willems, H. L., & Swinkels, D. W. (2008) · Haematologica · doi:10.3324/haematol.11705 · Cited by 313
Peña-Rosas, J. P., & Viteri, F. E. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub3 · Cited by 279
P HYSIOLOGY AND M OLECULAR B IOLOGY OF D IETARY I RON A BSORPTION
Miret, S., Simpson, R. J., & McKie, A. T. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073139 · Cited by 271
Anemia: Not Just an Innocent Bystander?
Nissenson, A. R., Goodnough, L. T., & Dubois, R. W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1400 · Cited by 208
Davidsson, L., Kastenmayer, P., Szajewska, H., Hurrell, R. F., & Barclay, D. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1597 · Cited by 123
Scott, R. A. M. (1948) · BMJ · doi:10.1136/bmj.1.4563.1195 · Cited by 118
Iron homeostasis and inherited iron overload disorders: an overview
Heeney, M. M., & Andrews, N. C. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.06.018 · Cited by 61
Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
Kaltwasser, J., Werner, E., & Niechzial, M. (1987) · PubMed · Cited by 40
IRON-DEFICIENCY ANÆMIA IN PREGNANCY
Gatenby, P. B. B., & Lillie, E. W. (1955) · The Lancet · doi:10.1016/s0140-6736(55)90543-2 · Cited by 40
Jacobs, P., Fransman, D., & Coghlan, P. (1993) · Journal of Clinical Apheresis · doi:10.1002/jca.2920080207 · Cited by 39
Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia
Ruiz-Argüelles, G. J., Díaz-Hernández, A., Manzano, C., & Ruiz‐Delgado, G. J. (2007) · Hematology · doi:10.1080/10245330701214160 · Cited by 39
Side‐Effect Studies on a New Sustained Release Iron Preparation
Rybo, G., & Sölvell, L. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb00873.x · Cited by 36
Jacobs, P., Johnson, G., & Wood, L. (1984) · PubMed · Cited by 35
Brock, C., Curry, H., Hanna, C., Knipfer, M., & Taylor, L. (1985) · PubMed · Cited by 33
Impact of parturition on iron status in nonanaemic iron deficiency
Krafft, A., Huch, R., & Breymann, C. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01244.x · Cited by 30
Bioavailability of iron from oral ferric polymaltose in humans.
Nielsen, P., Gabbe, E. E., Fischer, R. J., & Heinrich, H. C. (1994) · PubMed · Cited by 28
Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
Bopche, A. V., Dwivedi, R., Mishra, R., & Patel, G. S. (2009) · PubMed · Cited by 25
Iron formulations in pediatric practice.
Nagpal, J., & Choudhury, P. (2004) · PubMed · Cited by 24
Haliotis, F. A., & Papanastasiou, D. A. (1998) · PubMed · Cited by 23
Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study.
Jacobs, P., Wormald, L. A., & Gregory, M. C. (1979) · PubMed · Cited by 18
Assessment of iron availability using stable54Fe
Kaltwasser, J. P., Hansen, C., OEBIKE, Y., & Werner, E. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01392.x · Cited by 18
Hc, H. (1987) · PubMed · Cited by 17
Mára, M., Zivny, J., Eretová, V., Kvasnička, J., Kuzel, D., Umlaufová, A., & Márová, E. (2001) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2001.080002142.x · Cited by 17
Malhotra, S., Garg, S. K., Khullar, G. K., Malhotra, A. S., Kondal, A., Rana, H., & Sidhu, S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.6.831316 · Cited by 14
Reddy, P., Adsul, B. B., Gandewar, K. L., Korde, K. M., & Desai, A. (2001) · PubMed · Cited by 11
A comparative trial of slow-release and conventional iron preparations.
Pc, E., & Williams, G. D. (1970) · PubMed · Cited by 11
Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia.
Bc, M. (2003) · PubMed · Cited by 11
Iron hydroxide polymaltose--cause of persistent iron deficiency anemia at delivery.
Mehta, B. C. (2001) · PubMed · Cited by 10
Bc, M. (2002) · PubMed · Cited by 6
"Three systems together" programme of University of Science and Technology, Chittagong.
Bichile, S. K., & Kumar, V. (2002) · PubMed · Cited by 3
Clinical response to iron-polysaccharide complex in geriatric patients with iron-deficiency anemia.
Jf, S. (1968) · PubMed · Cited by 3
Mehta, B. C. (2001) · PubMed · Cited by 3
Hayhoe, F. G. J. (1960) · BMJ · doi:10.1136/bmj.1.5180.1195 · Cited by 3
Ozsoylu, S., & Özbek, N. (1991) · PubMed · Cited by 2
Research works printed but not linked: 23
- 2005, Iron deficience and other hypoproliferative anemias
- 2009, Cochrane Database of Systematic Reviews
- 2004, Indian Pediatrics, 41, 807
- 1979, South African Medical Journal, 55, 1065
- 2000, Revues Médicales Pédiatriques, 67, 63
- 1984, Journal of Medicine, 15, 367
- 1991, Experimental Hematology, 19, 1065
- 2001, Indian Journal of Medical Sciences, 55, 157
- 2002, Journal of the Association of Physicians of India, 50, 279
- 2002, The Journal of the Association of Physicians of India, 50, 617
- 2003, Journal of the Association of Physicians of India, 51, 419
- 1987, Arzneimittel-Forschung, 37, 122
- 1987, Drug Research, 37, 105
- 1994, Arzneimittel-Forschung/Drug Research, 44, 743
- 1993, British Journal of Clinical Research, 4, 191
- 2009, Indian Pediatrics, 46, 883
- 1998, International Journal of Clinical Pharmacology and Therapeutics, 36, 320
- 2000, JAMA India, 3, 53
- 2001, Journal of the Indian Medical Association, 99, 154
- 2001, Indian journal of medical sciences, 55, 616
- 1968, Michigan medicine, 67, 726
- 1970, Practitioner, 204, 812
- 1985, Clinical Therapeutics, 7, 568
Cited by
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833
“Since ferrous sulfate is the gold standard (most commonly prescribed) oral iron therapy in the UK and many other countries [10,31], our aim was to quantify the odds ratio for oral ferrous sulfate- associated gastrointestinal side-effects versus placebo or IV iron.”
BackgroundYanatori, I., & Kishi, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.020 · Cited by 351
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Batchelor, E. K., Kapitsinou, P., Pergola, P. E., Kovesdy, C. P., & Jalal, D. I. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020213 · Cited by 334
Iron considerations for the athlete: a narrative review
Sim, M., Garvican-Lewis, L. A., Cox, G. R., Govus, A., McKay, A. K. A., Stellingwerff, T., & Peeling, P. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04157-y · Cited by 274
MANTADAKIS, E. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.041 · Cited by 196
Metadata
- Authors
- Santiago, P.
- Affiliations
- Instituto Palacios (ES)
- Corresponding author
- Santiago, Palacios
- Venue
- The Scientific World Journal
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-5
- ISSN
- 1537-744X (ISSN-L)
- PMC
- PMC3354642
- OpenAlex
- W2066006975
- Cited by
- 210
- References
- 42
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 13 · 2023: 22 · 2022: 20 · 2021: 29 · 2020: 23 · 2019: 17 · 2018: 11 · 2017: 11 · 2016: 12 · 2015: 15 · 2014: 7 · 2013: 4
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Scientific World JOURNAL (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- Sanofi
- Les Laboratories Pierre Fabre
- Daiichi-Sankyo
- Servier
- Sanofi Pasteur
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- iron deficiency anemia, oral iron supplementation, ferrous iron, iron(III), ferrous sulfate, slow-release formulation, iron bioavailability, tolerability, efficacy, hemoglobin levels, iron stores
- MeSH terms
- Ferrous Compounds, Humans, Anemia, Iron-Deficiency, Iron, Dietary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.